Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

Hillary G. Caruso(The University of Texas MD Anderson Cancer Center), Lenka V. Hurton(The University of Texas MD Anderson Cancer Center), Amer Najjar(The University of Texas MD Anderson Cancer Center), David Rushworth(The University of Texas MD Anderson Cancer Center), Sonny Ang(The University of Texas MD Anderson Cancer Center), Simon Olivares(The University of Texas MD Anderson Cancer Center), Tiejuan Mi(The University of Texas MD Anderson Cancer Center), Kirsten C. Switzer(The University of Texas MD Anderson Cancer Center), Harjeet Singh(The University of Texas MD Anderson Cancer Center), Helen Huls(The University of Texas MD Anderson Cancer Center), Dean A. Lee(The University of Texas MD Anderson Cancer Center), Amy B. Heimberger(The University of Texas MD Anderson Cancer Center), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Laurence J.N. Cooper(The University of Texas MD Anderson Cancer Center)
Cancer Research
August 31, 2015
Cited by 396Open Access
Full Text

Abstract

Many tumors overexpress tumor-associated antigens relative to normal tissue, such as EGFR. This limits targeting by human T cells modified to express chimeric antigen receptors (CAR) due to potential for deleterious recognition of normal cells. We sought to generate CAR(+) T cells capable of distinguishing malignant from normal cells based on the disparate density of EGFR expression by generating two CARs from monoclonal antibodies that differ in affinity. T cells with low-affinity nimotuzumab-CAR selectively targeted cells overexpressing EGFR, but exhibited diminished effector function as the density of EGFR decreased. In contrast, the activation of T cells bearing high-affinity cetuximab-CAR was not affected by the density of EGFR. In summary, we describe the generation of CARs able to tune T-cell activity to the level of EGFR expression in which a CAR with reduced affinity enabled T cells to distinguish malignant from nonmalignant cells.


Related Papers

No related papers found

Powered by citation graph analysis